Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares Issued
Ratios

Ligand Pharmaceuticals (LGND) Shares Outstanding: 2010-2022

Historic Shares Outstanding for Ligand Pharmaceuticals (LGND) over the last 4 years, with Dec 2022 value amounting to $17.0 million.

  • Ligand Pharmaceuticals' Shares Outstanding rose 1.10% to $17.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $17.0 million, marking a year-over-year increase of 1.10%. This contributed to the annual value of $17.0 million for FY2022, which is 1.10% up from last year.
  • Ligand Pharmaceuticals' Shares Outstanding amounted to $17.0 million in Q4 2022, which was up 0.53% from $16.9 million recorded in Q1 2022.
  • In the past 5 years, Ligand Pharmaceuticals' Shares Outstanding registered a high of $21.3 million during Q1 2018, and its lowest value of $16.1 million during Q1 2020.
  • In the last 3 years, Ligand Pharmaceuticals' Shares Outstanding had a median value of $16.7 million in 2021 and averaged $16.5 million.
  • Its Shares Outstanding has fluctuated over the past 5 years, first dropped by 18.98% in 2019, then climbed by 4.27% in 2021.
  • Over the past 5 years, Ligand Pharmaceuticals' Shares Outstanding (Quarterly) stood at $20.8 million in 2018, then dropped by 18.98% to $16.8 million in 2019, then dropped by 4.42% to $16.1 million in 2020, then climbed by 4.27% to $16.8 million in 2021, then grew by 1.10% to $17.0 million in 2022.
  • Its last three reported values are $17.0 million in Q4 2022, $16.9 million for Q1 2022, and $16.8 million during Q4 2021.